Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions
Journal of Clinical Medicine · 18.09.2024 · 13 (18) · 5511
DOI: 10.3390/jcm13185511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.09.2024. Verfasst von Thierry Simonart und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Delta Hospital, CHIREC, Université Libre de Bruxelles, 1160 Bruxelles, Belgium. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Scabies is a prevalent dermatological condition with significant public health implications. The recent rise in drug-resistant scabies presents new challenges for effective disease management and control.
Methods
A comprehensive literature review was conducted using PubMed, Cochrane Library, and Web of Science. Studies published from 2000 to August 2024 were considered, focusing on those reporting drug-resistant scabies and advancements in treatment approaches.
Results
Clinical studies, in vitro investigations, and case reports show significant resistance of human scabies to permethrin. Main resistance mechanisms involve genetic mutations in the mites’ voltage-gated sodium channels (VGSCs) and enhanced activity or expression of the detoxifying enzyme glutathione S-transferase (GST). Resistance to ivermectin and benzyle benzoate, although suggested by some authors, seems less obvious. The clinical evidence of widespread ivermectin resistance in human scabies infestations is lacking, despite indications of increased tolerance in laboratory settings and anecdotal reports of resistance in patients with crusted scabies. Benzyl benzoate resistance in scabies mites remains unconfirmed.
Conclusions
Permethrin-resistant scabies is an escalating threat requiring new management strategies and updated guidelines. Infection control measures, alternative treatments, and ongoing research into new therapeutics are crucial to mitigate the impact of drug-resistant scabies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Delta Hospital, CHIREC, Université Libre de Bruxelles, 1160 Bruxelles, Belgium.
- Department of Dermatology, St Pierre-Brugmann-HUDERF University Hospitals, Université Libre de Bruxelles, 1000 Brussels, Belgium.
ORCID-Profile: Thierry Simonart, Xuân-Lan Lam Hoai
Zitieren
APA
Simonart, T., & Lam Hoai, X. L. (2024). Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions. Journal of Clinical Medicine, 13(18), 5511. https://doi.org/10.3390/jcm13185511
Vancouver
Simonart T, Lam Hoai XL. Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions. Journal of Clinical Medicine. 2024;13(18):5511. doi:10.3390/jcm13185511
BibTeX
@article{Simonart2024,
author = {Simonart, Thierry and Lam Hoai, Xuân-Lan},
title = {Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {18},
pages = {5511},
doi = {10.3390/jcm13185511}
}
EUVIMED